Lymphoplasmacytic Lymphoma Completed Phase 3 Trials for Doxorubicin (DB00997)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031072 (Lymphoplasmacytic Lymphoma) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00801281 | First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. | Treatment |